Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ensysce Biosciences (ENSC) Change in Taxes (2020)

Ensysce Biosciences (ENSC) has disclosed Change in Taxes for 1 consecutive years, with -$244469.0 as the latest value for Q4 2020.

  • On a quarterly basis, Change in Taxes changed N/A to -$244469.0 in Q4 2020 year-over-year; TTM through Dec 2020 was -$118792.0, a N/A change, with the full-year FY2020 number at -$118792.0, down 271.64% from a year prior.
  • Change in Taxes was -$244469.0 for Q4 2020 at Ensysce Biosciences, down from $264248.0 in the prior quarter.
  • In the past five years, Change in Taxes ranged from a high of $264248.0 in Q3 2020 to a low of -$244469.0 in Q4 2020.